EVALUATING THE ROLE OF A CaV2.2 SPLICE VARIANT IN BEHAVIORAL RESPONSES TO STRESS, NOVELTY, AND OTHER MONOAMINE-LINKED FUNCTIONS by Brennecke, Ashton
University of New Hampshire 
University of New Hampshire Scholars' Repository 
Master's Theses and Capstones Student Scholarship 
Winter 2019 
EVALUATING THE ROLE OF A CaV2.2 SPLICE VARIANT IN 
BEHAVIORAL RESPONSES TO STRESS, NOVELTY, AND OTHER 
MONOAMINE-LINKED FUNCTIONS 
Ashton Brennecke 
University of New Hampshire, Durham 
Follow this and additional works at: https://scholars.unh.edu/thesis 
Recommended Citation 
Brennecke, Ashton, "EVALUATING THE ROLE OF A CaV2.2 SPLICE VARIANT IN BEHAVIORAL RESPONSES 
TO STRESS, NOVELTY, AND OTHER MONOAMINE-LINKED FUNCTIONS" (2019). Master's Theses and 
Capstones. 1319. 
https://scholars.unh.edu/thesis/1319 
This Thesis is brought to you for free and open access by the Student Scholarship at University of New Hampshire 
Scholars' Repository. It has been accepted for inclusion in Master's Theses and Capstones by an authorized 






EVALUATING THE ROLE OF A CaV2.2 SPLICE VARIANT IN BEHAVIORAL 









Submitted to the University of New Hampshire 
in Partial Fulfillment of 
the Requirements for the Degree of 
 
Master of Science 
in 
Genetics 
December, 2019  
ii 
 
This thesis/dissertation has been examined and approved in partial fulfillment of the 

























Original approval signatures are on file with the University of New Hampshire Graduate School.   
iii 
 
TABLE OF CONTENTS 
TABLE OF CONTENTS .................................................................................................................................... iii 
ABSTRACT ..................................................................................................................................................... iv 
BACKGROUND ............................................................................................................................................... 1 
EVALUATING THE ROLE OF A CaV2.2 SPLICE VARIANT IN BEHAVIORAL RESPONSES TO STRESS, NOVELTY, 
AND OTHER MONOAMINE-LINKED FUNCTIONS ......................................................................................... 13 
INTRODUCTION ....................................................................................................................................... 13 
EXPERIMENTAL PROCEDURES ................................................................................................................. 18 
RESULTS .................................................................................................................................................. 30 
DISCUSSION ............................................................................................................................................. 53 
ACKNOWLEDGEMENTS ........................................................................................................................... 57 






EVALUATING THE ROLE OF A CaV2.2 SPLICE VARIANT IN BEHAVIORAL 
RESPONSES TO STRESS, NOVELTY, AND OTHER MONOAMINE-LINKED FUNCTIONS 
by 
Ashton Brennecke 
University of New Hampshire, December, 2019 
CaV2.2 (N-type) channel is a presynaptic channel that enables calcium influx into axon 
terminals, thereby playing a vital role in coupling action potentials to neurotransmitter release in 
the central and peripheral nervous systems. In vitro studies of CaV2.2 show that the channel 
directly modulates levels of the monoamines including dopamine, serotonin, and norepinephrine. 
Further, CaV2.2-null mice exhibit heightened aggression and hyperlocomotion linked to aberrant 
dopamine and serotonin function. All these studies suggest that CaV2.2 plays a pivotal role in 
monoaminergic function. CaV2.2 contains an alternatively spliced exon, e18a, which is either 
included (+18a-CaV2.2) or removed (Δ18a-CaV2.2) from the channel and alters calcium influx 
through CaV2.2 in vitro. +18a-CaV2.2 is expressed as the dominant isoform in midbrain 
monoaminergic areas including the substantia nigra, the ventral tegmental area, the dorsal raphe 
nuclei, and the locus coeruleus, as well as sympathetic system in the periphery. Its selective 
expression and modulation of CaV2.2 calcium current suggest that e18a could play a role in 
modulating midbrain monoaminergic communication and function. To study the potential in vivo 
effects of e18a, we utilized an e18a mouse where this exon was removed (Δ18a-only) and a 
battery of behavioral tests to assess monoamine function. We found that mice lacking 18a show 
deficits in their responses to inescapable stress. We have also demonstrated that these defects are 
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not attributed to alterations in basal exploratory behavior, appetitive reward, or nociception. Our 
results point at a novel role of CaV2.2 alternative splicing in stress responses and a possible link 






Voltage-Gated Calcium Channels 
Voltage-gated calcium channels (VGCCs or CaVs) are transmembrane proteins which 
collectively function to allow selective entry of calcium ions into the cell. The calcium that 
enters through this channels carries out important functions including neurotransmitter release 
(Catterall, 1999; Dunlap, Luebke, & Turner, 1995), gene expression (Barbado, Fablet, Ronjat, & 
De Waard, 2009), mRNA stability (Schorge, Gupta, Lin, McEnery, & Lipscombe, 1999), muscle 
contraction (Bers, 2002; Kuo & Ehrlich, 2015), cardiac pacemaker activity (Mesirca, Torrente, & 
Mangoni, 2015; Perez-Reyes, 2003), and neurite outgrowth (Komuro & Rakic, 1992, 1998; 
Rusanescu, Qi, Thomas, Brugge, & Halegoua, 1995).  
VGCCs are heteromultimeric complexes composed of multiple noncovalently interacting 
proteins encoded by different genes (Fig. 1). The largest member of the VGCC complex is the 
CaVα1 subunit, which forms the selectivity filter for calcium entry and serves as a target for 
toxins, drugs, and second messengers (Catterall & Striessnig, 1992; Diane Lipscombe & 
Andrade, 2015). The CaVα1 subunit is composed of four membrane-embedded domains (DI-
DIV) which are connected by intracellular linker regions (LI-II, LII-III, and LIII-IV). Each 
domain consists of six homologous transmembrane segments (S1-S6) and a re-entrant loop 
between S5 and S6. The S4 transmembrane segment of each domain contains charged arginines 
and lysines that are thought to act as voltage sensors (Dolphin, 2006). The CaVα1 subunit 
interacts with the auxiliary subunits include CaVβ and CaVα2δ. These subunits fine tune 
biophysical and pharmacological properties of the CaVα1 subunit (Walker & De Waard, 1998). 
The CaVβ subunits interact with the I-II linker region and their primarily role is to promote 
trafficking of the CaVα1 subunit to the membrane (Weiss & Zamponi, 2017), although they also 
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influence channel gating (Dolphin, 2006). The Cavα2δ subunit also plays a role in cell surface 
expression and channel kinetics (Dolphin, 2013; Nieto-Rostro, Ramgoolam, Pratt, Kulik, & 
Dolphin, 2018); however, it is primarily known for mediating the analgesic action of the drugs 
gabapentin and pregabalin (Davies et al., 2007; Field et al., 2006). It is worth noting that a third, 
CaVγ subunit has been copurified with the CaVα1 subunit and is thought to play an inhibitory role 
on calcium currents through CaVs (Snutch, Peloquin, Mathews, & McRory, 2005), however it 




Figure 1. Structural diagram of a voltage-gated calcium channel (VGCC, or CaV) with CaVα1, CaVβ, and CaVα2δ 
subunits (CaVγ subunit not shown). The CaVα1 subunit is divided into four domains (DI-DIV) consisting of six 
transmembrane segments (SI-SVI) connected by SVI-SI intracellular linkers (LI-II, LII-III, LIII-IV). Each domain 
contains a putative voltage sensing region shown in red (S4) and a re-entrant S5-S6 loop, shown in dark blue. The 
CaVβ subunit is entirely intracellular and interacts with the I-II linker, while the CaVα2δ subunit associates with the 








Ten unique genes (CACNA1A-I and S) encode different CaVα1 subunits, and they are 
subdivided into three subfamilies: CaV1, CaV2, and CaV3 (Table 1). These subfamilies exhibit 
different pharmacological and gating properties (Tsien, Lipscombe, Madison, Bley, & Fox, 
1988). 
Table 1. Voltage-gated calcium channel nomenclature and classification based on channel physiology. CaV2.2 is 
highlighted in yellow. 
Gene Protein Subunit Name Current Type Activation Threshold 
CACNA1S CaV1.1 α1S L-type HVA 
CACNA1C CaV1.2 α1C L-type HVA 
CACNA1D CaV1.3 α1D L-type HVA 
CACNA1F CaV1.4 α1F L-type HVA 
CACNA1A CaV2.1 α1A P/Q-type HVA 
CACNA1B CaV2.2 α1B N-type HVA 
CACNA1E CaV2.3 α1E R-type HVA 
CACNA1G CaV3.1 α1G T-type LVA 
CACNA1H CaV3.2 α1H T-type LVA 
CACNA1I CaV3.3 α1I T-type LVA 
 
 
The CaV1 family contains CaV1.1-1.4, encoded by CACNA1S (CaV1.1), CACNA1C 
(CaV1.2), CACNA1D (CaV1.3), and CACNA1F (CaV1.4). Each of these channels is high-voltage 
activated (HVA) and L-type, exhibiting “long-lasting” currents. They are expressed in smooth, 
skeletal, and cardiac muscle as well as neurons, endocrine cells, cochlear hair cells, and retinal 
cells (Schampel & Kuerten, 2017). This family is also sensitive to dihydropyridines (DHPs), 
pharmacological agents that allosterically block L-type channels (Catterall & Striessnig, 1992) 
and are used in the treatment of cardiovascular disease (Godfraind, 2014).  
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The CaV2 gene family includes CACNA1A (CaV2.1), CACNA1B (CaV2.2), and CACNA1E 
(CaV2.3). CaV2.1 generates P/Q-type (“Purkinje” type) currents, CaV2.2 generates N-type 
(“neuronal” type) currents, and CaV2.3 generates R-type (“resistant” type) currents. These 
channels are both DHP-insensitive and HVA, although they respond to lower voltages compared 
to L-type channels (Nowycky, 1985). CaV2s are primarily neuronal and are located in the 
presynaptic terminals, playing a major role in coupling excitation to fast neurotransmitter release 
(Catterall, 2011; Reid, Bekkers, & Clements, 2003; Weyrer et al., 2019; Wheeler, Randall, & 
Tsien, 1994).   
The CaV3 subfamily is comprised of CaV3.1-3.3, encoded by CACNA1G (CaV3.1), 
CACNA1H (CaV3.2), and CACNA1I (CaV3.3).  These channels are low-voltage activated (LVA) 
and produce T-type (“tiny” or “transient”) currents. They are called tiny because their single 
channel conductance is smaller than the other CaVs and transient because they activate and 
inactivate faster than the rest of the CaVs (Perez-Reyes, 2003). These channels are expressed in 
neuronal cells of the brain but can also be found in endocrine, muscular, and reproductive tissue 
(Catterall, 2011). CaV3 channels have been implicated in pacemaking activity of neurons (Perez-
Reyes, 2003), oscillatory behavior of the thalamus (Destexhe, Neubig, Ulrich, & Huguenard, 
1998), and maintenance of automaticity in the heart’s rhythmogenic centers (Mesirca et al., 
2015). 
The focus of my thesis is on CaV2.2 channels (highlighted in Table 1) for the reasons I 




Functional Importance of CaV2.2 
CaV2.2 channels are primarily located in the presynaptic terminal of neurons in the 
central and peripheral nervous system (Chai et al., 2017; Yokoyama et al., 1995). As stated 
above, CaV2.2 is an HVA channel that opens at membrane potentials of roughly –30 to +60 mV 
(Thaler, Gray, & Lipscombe, 2004) and inactivates in response to maintained depolarizations 
(Hirning et al., 1988). This channel utilizes a synprint (SYNaptic PRotein INTeraction) 
recognition sequence within the II-III linker that binds SNARE (SNAP-25 Receptor) vesicular 
docking proteins to facilitate fusion of neurotransmitter vesicles with the presynaptic membrane 
(Harkins, Cahill, Powers, Tischler, & Fox, 2004; He et al., 2018; Szabo, Obermair, Cooper, 
Zamponi, & Flucher, 2006). These proteins include synaptotagmin-1 (SYT1), SNAP-25 
(synaptosomal nerve-associated protein 25), and syntaxin 1A, as well as, active zone proteins 
such as RAB3A-interacting molecules (RIMs) and RIM-binding proteins (RIM-BPs) (Catterall, 
1999; He et al., 2018). CaV2.2 channels are selectively and irreversibly blocked with the Conus 
geographus snail toxin, ω-conotoxin GVIA (ω-CgTx) (Dooley, Lupp, & Hertting, 1987; Ellinor, 
Zhang, Horne, & Tsien, 1994). Bathing nervous tissues and synaptosomes in ω-CgTx has been 
shown to decrease γ-aminobutyric acid (GABA), glutamate, acetylcholine (ACh), dopamine, and 
norepinephrine release, indicating the importance of CaV2.2 in multiple types of 
neurotransmission (Dunlap et al., 1995).  
CaV2.2 channels have been directly linked to transmission of painful stimuli at the spinal 
cord level. Ziconotide, another potent CaV2.2 blocker created from ω-conotoxin MVIIA, is 
currently used to treat chronic neuropathic and inflammatory pain (S. Lee, 2013; Striessnig, 
2018). Ziconotide is injected intrathecally and is thought to suppress signaling between the 
dorsal root ganglia nociceptive fibers and neurons located in the dorsal horn of the spinal cord by 
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blocking CaV2.2 channels (Bell, Thaler, Castiglioni, Helton, & Lipscombe, 2004). Ziconotide 
has been shown to be more effective than morphine with significantly less potential for abuse 
(Scott, Wright, & Angus, 2002); however, administration is uncomfortable, the drug can cause 
motor defects at high doses, and hypotension can occur if it enters the bloodstream (McGivern, 
2007). Therefore, despite the existence of CaV2.2-specific drugs, further research is warranted to 
target cell- or tissue-specific CaV2.2 activity.  
In addition to its role in pain, the medical and behavioral relevance of CaV2.2 has been 
studied in CaV2.2 knock-out mouse models (CaV2.2-KO). Superior cervical ganglia (SCG) 
neurons and sympathetic nerve terminals of mice lacking functional expression of CaV2.2 exhibit 
markedly diminished activity, and the mice themselves suffer from hypertension and lack of 
baroreflex (Ino et al., 2001). Additionally, CaV2.2-KO mice experience disturbances in their 
sleep-wake cycles, hyperactivity, and reductions in sensorimotor gating compared to wild type 
(WT) mice (Beuckmann, Sinton, Miyamoto, Ino, & Yanagisawa, 2003; Nakagawasai et al., 
2010). These mice also exhibit behavioral changes which could be indicative of monoaminergic 
involvement—this topic will be discussed in greater detail in the Introduction. Taken together, 
the functional expression of CaV2.2 is an important component of nociception, maintenance of 
sympathetic homeostasis, and regulation of appropriate activity levels, as well as appropriate 
responses to monoaminergic communication. 
  
Alternative Splicing of Cacna1b 
 Alternative splicing is a fascinating component of RNA processing that takes place in 
>90% of mammalian cells and is incredibly common in neuronal genes (Diane Lipscombe & 
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Lopez Soto, 2019). Within the nucleus, eukaryotic DNA is transcribed to immature pre-mRNA 
which contains both exons and introns. Small nuclear ribonucleoparticles (snRNPs) composed of 
disparate proteins come together to form the spliceosome which uses recognition sequences 
within introns to cut and fold the intron into a lariat shape. The spliceosome then connects the 3’ 
end of the first exon to the 5’ end of the second exon, thereby cleaving the intron out and 
precisely fusing the exons to one another (Y. Lee & Rio, 2015). In the same way, alternatively 
spliced exons can also be spliced out to further specialize the mRNA for a particular cellular 
function. Addition of a 5’ 7-methylguanosine cap and a 3’ poly-A tail creates a mature mRNA 
molecule which can leave the nucleus and be transcribed into a protein (Katahira, 2015). 
Through this process, cells dramatically increase protein diversity while maintaining a low 
genetic load.  
As technological advancements make it easier to study alternative splicing, a clearer 
picture of its involvement in disease and genetic therapy has begun to emerge. Neuronal genes 
have been implicated in disorders such as Rett syndrome (Osenberg et al., 2018), autism (Lu, 
Dai, Martinez-Agosto, & Cantor, 2012; Quesnel-Vallières et al., 2016), spinal muscular atrophy 
(SMA) (Cartegni & Krainer, 2002), parkinsonism (Farrer, 2006; Satake et al., 2009), chronic 
pain (Manners, Ertel, Tian, & Ajit, 2016), and cancer (Fan et al., 2018). Alternatively spliced 
Cavs also modify the severity of diseases like spinocerebellar ataxia type 6 (SCA6) (Zhuchenko 
et al., 1997) and Timothy syndrome (Diane Lipscombe, 2005; Splawski et al., 2005). Taken 
together, alternative splicing is an important regulator of normal cell function and shows promise 
as a target for genetic therapy. 
 Cacna1b is the gene that encodes the 1 pore-forming subunit of CaV2.2 channels. The 
Cacna1b pre-mRNA undergoes a number of alternative splicing events which are both cell-
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specific and developmentally regulated. In mouse, the channel contains at least five alternatively 
spliced exons (e18a, e20a, e24a, e31a, and e37a/e37b; Figure 2) and at least three more putative 
sites of alternate 5’ or 3’ splicing (D. Lipscombe, Qian Pan, & Gray, 2002). Additionally, studies 
of human brain and central nervous tissue have demonstrated presence of CaV2.2 isoforms which 
contain large deletions. One of these occurs in the II-III linker, where deletion of exons 19, 20, 
and 21 makes the channel more resistant to voltage-dependent inactivation and less responsive to 
ω-conotoxins GVIA and MVIIA (D. Lipscombe et al., 2002). Another splicing event gives rise 
to either a long channel form or a short form which is truncated by 187 nucleotides at the C-
terminus (Williams et al., 1992). Only the long form of the channel binds neuronal Munc18-1-
interacting protein 1 (Mint1) and calcium/calmodulin-dependent serine protein kinase (CASK) 
proteins, potentially implicating this event in CaV2.2 channel density and the effectiveness of 




Figure 2. Alternatively spliced exons of the mouse CaV2.2-α1 subunit gene, Cacna1b. Membrane embedded 
structure with approximate locations of alternatively spliced exons are shown (left) as well as the unfolded structure 
(right). CaV2.2-α1 contains at least five alternatively spliced exons: 18a and 20a in the II-III linker, 24a and 31a in 
the S3-S4 extracellular portions of DIII and DIV (respectively), and 37a/37b in the C-terminus.  
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Of the alternatively spliced exons, the most e37a/e37b are the most studied. These exons 
are mutually exclusive (either e37a or e37b is included in the final Cacna1b mRNA), and encode 
33 amino acids of the C-terminus of the channel. E37a has been found to control CaV2.2 gene 
expression and modulation by G-protein coupled receptors (GPCRs) (Raingo, Castiglioni, & 
Lipscombe, 2007). While e37b is extensively expressed in central and peripheral nervous tissues, 
e37a is abundantly expressed in the dorsal root ganglia (DRG) and is enriched in nociceptors, 
sensory receptors involved in the first step of pain sensing (Bell et al., 2004; Jiang, Andrade, & 
Lipscombe, 2013), In the pain pathway, e37a is linked to both thermal and mechanical 
hyperalgesia during transmission of nociceptive signals (Altier et al., 2007). In line with these 
findings, e37a also appears to enhance the analgesic effects of intrathecal morphine 
administration, although interestingly it is not involved in ziconotide-induced analgesia 
(Andrade, Denome, Jiang, Marangoudakis, & Lipscombe, 2010; Jiang et al., 2013).  In the brain, 
e37a is localized in excitatory pyramidal neurons and is linked to behavioral responses to 
aversive stimuli (Bunda, LaCarubba, Bertolino, et al., 2019). These observations suggest that 
alternative splicing in calcium channel genes can fine tune VGCC expression, function, and have 
therapeutic relevance. 
Exons 20a, 24a, and 31a are cassette exons, being either included or skipped in the 
mature mRNA. In mice, e20a is located in the II-III linker and encodes a premature stop codon, 
rendering the channel incomplete and nonfunctional (Raghib et al., 2001). This exon likely 
works to suppress CaV2.2 protein expression via nonsense-mediated decay, particularly during 
development (Diane Lipscombe & Andrade, 2015). E24a and e31a are located in the 
extracellular IIIS3-IIIS4 and IVS3-IVS4 linkers, respectively. While e24a is preferentially 
expressed in the brain, e31a is preferentially expressed in the peripheral ganglia (Diane 
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Lipscombe, Allen, & Toro, 2013). This reciprocal expression pattern is due to e31a suppression 
by the splicing factor Nova-2 (Allen, Darnell, & Lipscombe, 2010; Diane Lipscombe, Andrade, 
& Allen, 2013). Compared to e24a, presence of e31a in CaV2.2 leads to a more depolarized 
voltage of activation and slower channel opening (Lin, Haus, Edgerton, & Lipscombe, 1997; Lin 
et al., 1999). In this case, alternative splicing is used by cells of the central nervous system to 
specialize the function of neuronal populations. 
 
Characterization of e18a Splice Isoforms 
In my thesis work, I focused on the cassette exon 18a (e18a) of CaV2.2. Alternative 
splicing of e18a generates two distinct CaV2.2 variants, one which includes e18a (+18a-
Cacna1b) and one which does not (18a-Cacna1b). Several reasons motivated me to study this 
exon: i) e18a is evolutionarily conserved across vertebrates (Allen et al., 2017); ii) e18a encodes 
a 21-amino acid sequence that is rich in serine and threonine residues, indicating a potential 
target for protein kinases (Pan & Lipscombe, 2000); iii) e18a lies within the synprint region of 
the II-III linker, suggesting some involvement in CaV2.2-mediated exocytosis (Catterall, 1999; 
Harkins et al., 2004); iv) e18a protects CaV2.2 from cumulative inactivation following trains of 
action potentials, and it protects CaV2.2 channels from closed-state inactivation (Thaler et al., 
2004); v) e18a also shifts steady-state inactivation of CaV2.2 to more depolarized potentials, 
making it more difficult for the channel to become inactivated (D. Lipscombe et al., 2002; Pan & 
Lipscombe, 2000); and vi) channels that include e18a have about twofold greater calcium current 
density than their Δ18a-CaV2.2 counterparts (Allen et al., 2017; see Figure 3). All these 
observations suggest that the splicing of e18a may have robust implications for CaV2.2 channel 




Figure 3. Impacts of e18a inclusion (+18a) and exclusion (Δ18a) on CaV2.2 channel physiology in HEK293 cells. 
Data is shown as mean ± SEM and n is shown in parentheses. Starting at a test potential of -20 mV, +18a-CaV2.2 
channels demonstrate increased calcium current density (pA/pF) relative to cell size when compared with Δ18a-
CaV2.2 channels. At peak current density, +18a-CaV2.2 exhibits approximately double the calcium current of Δ18a-
CaV2.2 channels (Allen et al., 2017). 
 
 
E18a demonstrates a unique expression pattern that changes with both development and 
tissue identity. During postnatal development, e18a increases in the central and peripheral 
nervous systems. In human whole brain samples, e18a is only expressed in about 12% of all 
CACNA1B mRNAs and is undetectable in fetal samples. In newborn mouse SCG, e18a inclusion 
is only about 35%, but over the course of development we see a gradual shift to >80% inclusion 
in adult (Allen et al., 2017; Pan & Lipscombe, 2000). The expression of e18a also depends on 
the tissue. In adult, e18a is only included in 10-30% of CACNA1B mRNAs from human 
cerebellum, dorsal root ganglia (DRG), hippocampus, and cortex (Allen et al., 2017). Similar 
observations have also been made in mouse tissue analyses. This nicely aligns with the 
conservation of this exon among humans and rodents.  In a separate study, it was also 
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demonstrated that rat monoaminergic regions preferentially express the +18a-CaV2.2 variant. 
While results in other regions consistently expressed low levels of e18a, mean expression of 
+18a-CaV2.2 in monoaminergic regions including the ventral tegmental area (VTA), substantia 
nigra (SN), dorsal raphe (DR), and locus coeruleus (LC) was higher than Δ18a-CaV2.2 
(Ghasemzadeh, Pierce, & Kalivas, 1999). 
Because e18a has such a distinct pattern in monoaminergic areas of the brain and SCG, it 
is possible that the exon is involved in fine tuning peripheral and central monoaminergic 
function. The primary objective of my work was to perform a thorough behavioral 
characterization of mice lacking e18a (Δ18a-only) in order to better understand its role in 
baseline and monoamine-linked behaviors including mobility, stress coping, and drug response. 
A secondary objective was to use BaseScope™ in situ hybridization to determine the presence 
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Monoamines are powerful neuromodulators that are essential components of reward 
(Alhadeff et al., 2019; Schultz, 2013), motor coordination (Crocker, 1997; Rommelfanger et al., 
2007), satiation (Augustine et al., 2019; Sandhu et al., 2018), stress (Belujon & Grace, 2015; 
Chaouloff, Berton, & Mormède, 1999; Habib, Gold, & Chrousos, 2001), attention (Del Campo, 
Chamberlain, Sahakian, & Robbins, 2011; Nieoullon, 2002; Weinberg-Wolf et al., 2018), arousal 
(Buchanan & Richerson, 2010; Haxhiu, Tolentino-Silva, Pete, Kc, & Mack, 2001) , and 
motivational salience (Berridge, 2012; Puglisi-Allegra & Ventura, 2012), among others. This 
class of neurotransmitters includes dopamine, serotonin, and norepinephrine, small molecules 
which regulate these behaviors. Alterations in the signaling of these three monoamines are linked 
to neurological and psychiatric disorders including Parkinson’s disease (Dickson, 2012), 
addiction (Koob & Volkow, 2010), anxiety (de la Mora, Gallegos-Cari, Arizmendi-García, 
Marcellino, & Fuxe, 2010; Mohammad-Reza & Fatemeh, 2015; Nishitani et al., 2019), 
schizophrenia (Breier, 1995; Grace, 2016), depression (Grace, 2016; Moret & Briley, 2011; 
Owens & Nemeroff, 1994), and posttraumatic stress disorder (Krystal & Neumeister, 2009; 
Segman et al., 2002).  
Dopamine, serotonin, and norepinephrine are primarily produced and released from 
groups of neurons located in the midbrain. Dopaminergic regions include the VTA and SNc; 
these neurons target many areas of the brain including the nucleus accumbens (NAc) and the 
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caudate putamen (CPu, or dorsal striatum) (Poulin et al., 2018). Serotonergic projections stem 
primarily from the DRN and project to much of the cortex as well as the hypothalamus, the 
amygdala, the VTA, and part of the hippocampus (Hornung, 2003). The largest collection of 
noradrenergic neurons exists in the LC (Schwarz & Luo, 2015). Despite its small size, this region 
plays a major role in many central nervous functions. Regions innervated by the LC include the 
DRN, the cerebellum, motor neurons of the brainstem and spinal cord, cortical regions in every 
lobe of the brain, and parts of the limbic system including the amygdala and hippocampus 
(Samuels & Szabadi, 2008). Taken together, these monoaminergic midbrain regions control 
numerous areas involved in mood and behavioral modulation. 
CaV2.2 is richly expressed in the DRN, the SNc, the VTA, and the LC (Tanaka, 
Sakagami, & Kondo, 1995). As previously described, this channel is believed to play a vital role 
in neurotransmitter release by triggering the fusion of presynaptic vesicle docking proteins with 
the cellular membrane (Harkins et al., 2004) . Calcium influx through CaV2.2 drives the release 
of dopamine in the VTA and SNc (Brimblecombe, Gracie, Platt, & Cragg, 2015) and blockade of 
CaV2.2 reduces dopamine efflux (Phillips & Stamford, 2000). Although we are not aware of 
direct evidence linking CaV2.2 to LC, selective blockade of CaV2.2 using ω-CgTx significantly 
hindered noradrenaline release in superior cervical ganglia (SCG) cultures (Hirning et al., 1988) 
and inhibited evoked tritium overflow in rabbit hippocampal slices labeled with 
[3H]noradrenaline (Dooley, Lupp, & Hertting, 1988), indicating that CaV2.2 could modulate 
noradrenaline release in central and peripheral tissues. Similarly, ω-CgTx significantly inhibited 
serotonin release in rat brain slices (Bagdy & Harsing, 1995; Rijnhout, Hill, & Middlemiss, 
1990), although we are not aware of a direct connection between CaV2.2 and DRN serotonin 
release. Therefore, more work will be needed to elucidate the exact role of CaV2.2 in these areas. 
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Mice lacking the functional expression of CaV2.2 (or “knock- out” mice) also show 
phenotypes linked to alterations in monoaminergic signaling. These phenotypes include basal 
and novelty-induced hyperactivity (Beuckmann et al., 2003), spontaneous locomotor activity 
during the dark phase (Nakagawasai et al., 2010), vigilance state differences (Beuckmann et al., 
2003), hyperlocomotion in response to apomorphine (a non-selective dopamine agonist) 
(Nakagawasai et al., 2010), diminished ethanol consumption and preference (Clayton & Hicks, 
1994; Newton et al., 2004), alterations in dopamine and serotonin levels and turnover 
(Nakagawasai et al., 2010), and basal hyperaggression which also mimics behavioral response to 
DRN CaV2.2 blockage (Kim et al., 2009). This body of evidence suggests that CaV2.2 represents 
an important molecular target within all three of these monoaminergic pathways. 
During Cacna1b gene expression, exon 18a (e18a) within the intracellular DII-DIII linker 
region is spliced to produce either +18a-CaV2.2 or Δ18a-CaV2.2 (Fig. 4). E18a falls within the 
synprint region, a sequence that targets CaV2.2 to the terminal membrane (Szabo et al., 2006), 
and is also believed to couple calcium influx to exocytosis via interactions with vesicular 
docking proteins (Harkins et al., 2004). Prior experiments have shown that e18a shifts the 
voltage dependence of closed-state inactivation of CaV2.2, it imparts the channel with resistance 
to closed-state inactivation, and it produces calcium conductance which is nearly double that of 
Δ18a-CaV2.2 channels (Allen et al., 2017; Thaler et al., 2004). Therefore, it is expected that 
channels without e18a (Δ18-CaV2.2) would release neurotransmitter less effectively than their 
+18a-CaV2.2 counterparts. 
Previous studies provide strong evidence that the +18a-Cav2.2 splice variant is enriched 
in midbrain regions that produce dopamine (VTA and SNc), serotonin (DRN), and noradrenaline 
(LC). In an early study, RT-PCR of microdissected tissue from each of these areas shows a shift 
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to +18a-CaV2.2 isoform dominance when compared to regions such as prefrontal cortex, 
hippocampus, nucleus accumbens, and striatum (Ghasemzadeh et al., 1999). Work from a 
previous member of our lab also confirmed these findings using the BaseScope™ assay. In brief, 
this technique is a highly sensitive form of in situ hybridization in which mRNA transcripts as 
small as 50 bp can be visualized in tissue. Using probes which detected the 18:18a exon junction, 
Bunda and colleagues demonstrated that there is extensive e18a expression in all four of these 
midbrain monoaminergic areas. The expression pattern of e18a in these assays nicely aligned 
with the data from the Allen Brain Atlas showing expression patterns of Slc6a3, Slc6a4, and 
Slc6a2, encoding the dopamine transporter (DAT), serotonin transporter (SERT), and the 
norepinephrine transporter (NET), respectively (Bunda, LaCarubba, Akiki, & Andrade, 2019). 
These data in conjunction with previous studies of CaV2.2 in midbrain function implicate a 
potential role for e18a in monoaminergic function. 
Despite its selective expression and modulation of CaV2.2 gating properties, the 
behavioral relevance of e18a has not been elucidated. To better understand the role of e18a in 
vivo, we developed a transgenic mouse model in which e18a is globally deleted from the genome 






Figure 4. Alternative splicing of CaV2.2-e18a in wild type (WT) animals and Δe18a-only (Δ18a) mutant mouse 
model. Exon 18a is a cassette exon which is 63 bp in length and lies between constitutively expressed exons 18 and 
19. In the process of pre-mRNA splicing, WT Cacna1b can either include e18a (+e18a-Cacna1b) or skip e18a 
(Δe18a-Cacna1b), resulting in two forms of CaV2.2 (CaV2.2-+18a or CaV2.2-Δ18a). In our mouse model, exons 18 
and 19 are precisely fused together, resulting in global expression of Δe18a-Cacna1b transcripts and rendering all 







Male C57BL/6 mice (Charles River) were used as wild-type animals. The Δ18a-only 
mouse line was designed as follows. An 18a-CaV2.2 targeting construct was designed from the 
Sanger BAC clone BMQ175b12 (Adams et al., 2005) to induce targeted excision of e18a. About 
12 Kb of mouse genomic DNA were cloned into a pBluescript II KS (-) vector and a series of 
sequential site-directed mutagenesis steps were used to delete e18a and the introns which flank 
it. These steps were used to generate a construct in which e18 and e19 were precisely fused 
together. A plasmid containing the loxP-NeoR-loxP cassette was amplified and a targeted 
insertion was performed to insert the cassette between e17 and e18. Finally, approximately 3 Kb 
of Murid betaherpesvirus dsDNA containing the e20 gene were inserted into the construct to 
increase the total size to ~11 Kb. This was linearized and integrated into mouse ES129 cells via 
electroporation, then NeoR positive clone cells were selected and confirmed using PCR and 
southern hybridization. These clones were microinjected into the embryos of FVB/N mice and 
the F1 generation was created by mating the mice produced from these embryos with animals 
from a C57BL/6 background. This F1 generation was mated to a line containing Cre 
recombinase (B6.FVB-Tg(EIIacre)C5379Lmgd/J, The Jackson Laboratory stock number 
003724) to delete NeoR, and the resultant Neo- siblings were mated. Homozygous offspring 
were backcrossed to C57BL/6 (Charles river) mice to enhance the purity of their genetic 
background. These mice are recorded in the mouse genomics information database (MGI) and 
designated Cacna1btm4.1DiLi. 
Animals used for behavior analysis were both males and females. Unless otherwise 
noted, mice were group housed in rooms with a 12 h light/dark cycle and were provided food and 
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water ad libitum. All experimental procedures followed the guidelines of the Institutional Animal 
Care Committee of the University of New Hampshire. Animals were allowed to acclimate to 
housing conditions for at least one week prior to testing, and the researcher was blind to the 
genotype of all animals throughout testing and analysis. Prior to all behavior tests, mice were 
transferred and allowed to acclimate to the testing room for at least 30 minutes. In all cases, the 
scorer was blind to the genotype of the animal until testing and data analysis had been 
completed. 
 
Quantitative Real-Time PCR (qRT-PCR) 
Whole brain tissue was flash frozen in liquid nitrogen, and then transferred to dry ice. 
Individual whole brains from WT and Δ18a-only mice were pulverized with a mortar and pestle 
in the presence of liquid nitrogen. 30 mg of pulverized tissue was homogenized in RLT lysis 
buffer (Qiagen, 74134). RNA was extracted using Qiagen RNAeasy plus kit (Qiagen, 74134) 
according to manufacturer protocols. RNA was eluted in diethyl pyrocarbonate-treated water. 1 
µg of total RNA from sorted cells was primed with oligo-dT and reverse transcribed with 
Superscript IV First-Strand Synthesis System (ThermoFisher Scientific, 18091050) according to 
manufacturer instructions. To quantify the amounts of e37a relative to total Cacna1b mRNA, we 
used two sets of primers as done previously (Bunda, LaCarubba, Bertolino, et al., 2019). Briefly, 
the first set of primers amplified specifically e37a-containing transcripts. This set of primers 
consisted of a forward primer designed to target the splice junction between e36 and e37a (e36-
37aF: CTGCGTGTTGCCGGATT) and a reverse primer to target a sequence within e37a (e36-
37aR: 5’ACCTACGAGGGCAGTTCTT). The second set of primers amplified a segment 
containing the constitutive exons 35 and 36 (e35-36F: 5’ GGAAACATTGCCCTTGATGATG, 
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e35-36R: 5’ CAGTGGCACTCCTGAACAATA). This amplification was used to normalize e36-
37a amplification. The amplification efficiencies of both sets of primers was previously 
described (Bunda, LaCarubba, Bertolino, et al., 2019). All RT-qPCR reactions were run on an 
ABI 7500 Fast Real-Time PCR system (Applied Biosystems) with the following conditions: 1 
cycle 95 °C for 2 min, 45 cycles (95 °C for 15 s and 60 °C for 1 min). Each sample from at least 
five different mice per genotype (biological replicates) was run in triplicate (technical replicates).  
The specificity of 36-37a primers was described previously (Bunda, LaCarubba, Bertolino, et al., 
2019). Ct values were determined by 7500 Software v2.3 (Applied Biosystems). Relative 
quantification of gene expression was performed with the 2-ΔΔCt method (Livak & Schmittgen, 
2001).    
 
Western Blot  
Brains were extracted from mice P24-P28 and flash frozen in liquid nitrogen. Brains were 
homogenized in 1x RIPA buffer consisting of the following: 50 mM Tris HCl (pH 7.5), 150 mM 
NaCl solution, 1% Igepal CA-630, 0.5% sodium deoxycholate solution (sterile filtered), and 
0.1% sodium dodecyl sulfate with 1 pellet of protease inhibitors per 10 mL of buffer (cOmplete, 
Mini, EDTA-free; Sigma, 04 693 159 001). Homogenates were incubated on ice for 30 min and 
rehomogenized. Samples were centrifuged at 4°C for 10 min at 1,000 x g to remove debris and 
the pellet was discarded. The supernatant was then centrifuged for 20 min at 12,000 x g. The new 
supernatant was transferred to a separate tube for use and analysis. Bicinchoninic acid (BCA) 
assay was performed for protein quantification in samples (ThermoFisher, 23227) according to 
manufacturer’s instruction. Samples were adjusted to 2 μg/μL with RIPA buffer. Samples were 
denatured for 20 min at RT using a 1:1 ratio of sample and 2x reducing buffer which consisted of 
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the following: 100 mM Tris-HCl (pH 6.8), 4% w/v SDS, 0.2% w/v bromophenol blue, 20% v/v 
stock liquid glycerol, and 200 mM dithiothreitol in Milli-Q® H2O.  
Proteins were resolved using a 6% polyacrylamide resolving gel and a 4% stacking gel. 
The resolving gel was made fresh on the day of use from the following: 5.35 mL Milli-Q® H2O, 
2.5 mL 1.5 M tris HCl (pH 8.8), 2 mL 30% acrylamide/bis (BIO-RAD, #161-0158), 100 μL 10% 
SDS, 70 μL 10% APS (Sigma, #A-3678), and 10 μL TEMED (Sigma, #T22500). The resolving 
gel was covered with H2O-saturated n-Butyl alcohol, cured for 15 min, and rinsed with dH2O. 
The 4% stacking gel was prepared with the following: 3 mL Milli-Q® H2O, 1.25 1M tris HCl 
(pH 6.8), 665 μL 30% acrylamide/bis, 50 μL 10% SDS, 40 μL 10% APS, and 5 μL TEMED. 
Electrophoresis run buffer stock (10x) was prepared from 250 mM tris base, 2500 mM glycine, 
and 1% w/v SDS. This run buffer was diluted to 1x for electrophoresis. Once the gel was cured, 
samples and ~10 μL of WesternSure® Pre-stained Chemiluminescent Protein Ladder (Li-Cor, # 
926-98000) were loaded into the BIO-RAD mini-PROTEAN 3 system. Samples were run at 10 
mA per plate for 90 min, followed by 20 mA per plate for about another 30 min.  
Next, proteins were transferred to a polyvinylidene difluoride (PVDF) membrane using a 
transfer buffer. A 5x stock was prepared in Milli-Q® H2O by adding 125 mM tris base, 950 mM 
glycine, and 0.5% w/v SDS. This stock was diluted to 1x by combining 260 mL 5x stock, 195 
mL methanol, and 845 mL Milli-Q® H2O. Prior to transfer, the PVDF membrane and gel were 
equilibrated for 20 min in 100% methanol and 1x transfer buffer, respectively, for 20 min. 
Transfer was performed on ice for 1 hr at 100 V. 1x PBS-Tween (PBS-T) was made by adding 5 
mL of 20% Tween-20 solution (Sigma, P5927) to 1 L of 1x PBS in Milli-Q®. Following transfer, 
the membrane was rinsed with 1x PBS-T and allowed to dry overnight.  
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The PVDF membrane was reactivated in 100% methanol for 1 min followed by a brief 
PBS-T rinse step. The membrane was incubated with REVERT total protein stain (Li-Cor #926-
11014) on an orbital rocker for 5 min. Stain was decanted, and the membrane was rinsed twice 
with wash solution for 30 s followed by a brief PBS-T rinse and subsequent storage in light-
protected PBS-T. At this point, the membrane was imaged using an Odyssey CLx imaging 
system on the 700 nm channel. 
After rinsing with PBS-T, the membrane was blocked with 5% BSA in PBS-T at RT for 
1 hr. Next, it was washed three times for 3 min per wash in PBS-T. Anti-CaV2.2 primary 
antibody (Alomone Rabbit anti-CaV2.2, #ACC-002) was diluted in 0.425 μg/μL in Milli-Q H2O 
and resuspended in 50% glycerol. Stock was prepared 1:100 with 1% BSA in PBS-T and 15 μL 
10% NaN3 for a final concentration of 0.425 μg/mL. Primary antibody incubation was carried 
out for 1 hr at RT with rocking, followed by three washes in PBS-T. The secondary antibody 
(Peroxidase-conjugated AffiniPure F(ab')2 Fragment Donkey Anti-Rabbit IgG (H+L); Jackson 
ImmunoLaboratories, Inc., 711-036-152) was prepared 1:15,000 in 1% BSA with PBS-T and 
incubated for 1 hr at RT with rocking. This was then decanted and the membrane was rinsed 
twice followed by three, 10-min washes in PBS-T with rocking. Signal was detected using ECL™ 
Western Blotting Detection Reagents (Sigma, GERPN2209) as per manufacturer’s instructions 
and developed on Amersham Hyperfilm ECL (Sigma, GE28-9068). 
Total protein stain and chemiluminescence images were analyzed using ImageJ software 
(NIH, http://imagej.nih.gov/ij, v.1.51j8). Images were converted to 8-bit grayscale for analysis. 
Using the gel analysis tools, each lane was selected for total protein, and equally-sized boxes set 
for CaV2.2 at approximately the 230-260 kDa position. Areas under the curves were used for 
densitometry and exported for quantitative analysis. Chemiluminescence images were 
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normalized to total stain fluorescence, and the ratio of CaV2.2 to total protein compared. Results 
were compared statistically by ANOVA with sex and genotype as factors, and Tukey post-tests. 
 
Behavior Assays 
Hot Plate Test 
 The surface of a Hot Plate 7280 (Ugo Basile, Swenksville, PA) was heated to a constant 
temperature of 50, 53 and 55oC. Mice were placed on the heated plate contained in a clear acrylic 
cage, and video-recorded for the duration of the test. Latency to paw lick, paw flick, or jump was 
measured offline in the videos. Mice were removed from the hot plate and returned to their home 
cage immediately after responding to heat. If a mouse was unable to show a response within 60 
s, the test was terminated. Scoring was done off line with a digital timer. 
Open Field Test 
 Both males and females were used for this test. All mice were habituated in the testing 
room for 30 minutes prior to testing. Following habituation, mice were placed inside the open-
field apparatus (a 45 x 45 cm open-top box, Harvard Apparatus, 76-0190) and activity was 
recorded for 5 minutes. The arena was divided into an “inner zone” which was in the center of 
the box and an “outer zone” which bordered one or more walls. Total distance traveled and 
percent of time in the inner zone were tracked using EthoVision XT version 11.5 behavioral 





Elevated Plus Maze 
 Both males and females were tested. Mice were habituated to the testing room at least 30 
minutes prior to testing. The maze was constructed from an elevated arena which contained four 
perpendicular arms that were 65 cm each and alternated between open (no walls) and closed 
(walled on 3 sides). Testing began when the mouse was dropped into the center of the arena, and 
each animal was tracked for 10 minutes. Total distance traveled and percent of time in the open 
arms were analyzed using EthoVision XT version 11.5 behavioral software (Noldus Information 
Technologies, Inc.). 
Saccharin Preference Test 
One week prior to preference testing, male mice were separated into single housing 
conditions. Drinking bottles were constructed using 50 mL conical tubes fitted with stoppers and 
ball bearings (VWR) and were fitted through slats in the roof of home cages. For 4 days, tap 
water was administered ad libitum in two separate drinking bottles to allow mice to acclimate to 
the two-bottle condition. On day 4, one of the solutions was replaced with 0.2% sodium 
saccharin salt hydrate (Sigma-Aldrich, S1002) in tap water. Bottles were then weighed every day 
for 4 days to assess consumption and compared against baseline preference measurements. The 
position of the bottles was counterbalanced across cages, positions, and days so as to avoid a side 
bias. 
Novelty-Induced Hypophagia 
This test was carried out three phases: three days of conditioning, one day of home cage 
testing, and one day of novel cage testing. Mice for this test were given at least one week to 
recover from saccharin preference testing before conditioning began and were kept singly 
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housed. Each day during the conditioning phase, mice were transferred in their home cages to a 
room with shaded lighting. Sweetened condensed milk (1:3 in tap water, Carnation®) was 
prepared fresh each day and delivered via leak-proof drinking bottles. Mice were allowed to 
drink ad libitum for 45 minutes. Home cage testing was performed for 10 minutes under similar 
conditions to create a baseline measurement of latency to drink and time spent drinking. On the 
final day, an empty cage was placed atop a white base and ~30 cm beneath two bright LED 
lights to invoke mild stress. Mice were recorded in the novel conditions for 10 minutes and 
latency to drink was manually scored against baseline measurements. 
Marble Burying Test 
Mice were acclimated to single housing in aspen chip bedding for 10 days in home cages 
prior to testing. Twenty marbles of varying colors were placed evenly across fresh beds of Aspen 
Hardwood Laboratory Bedding (Northeastern Products Corp.). Mice were individually placed in 
beds and given 1 hr to bury marbles. Irrelevant mice were given 30 minutes to dirty bedding 
before testing and bedding was not changed between trials. The number of marbles more than 
2/3 buried was manually scored based on images taken directly following each test. 
Cocaine-Conditioned Place Preference 
The conditioning apparatus consisted of two acrylic compartments (30 cm l x 15 cm w x 
15 cm h) with a removable divider separating the two and unique floors in each compartment. 
The “grid” floor was made from perforated stainless steel sheet with 40% open space and the 
“hole” floor was assembled from parallel ¼ cm stainless steel rods separated by about 1 cm open 
space. Cocaine hydrochloride (Sigma-Aldrich, C5776) was prepared at 2 mg/mL in sterile 0.9% 
sodium chloride (saline) and administered IP at 0.1 mL per 10 g body weight. This test was 
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divided into three phases: a baseline day, eight days of conditioning, and a final conditioned 
preference test. Each day of testing was separated by about 24 hrs, with a two-day break falling 
between the fourth and fifth days of conditioning. Mice were singly housed for at least a week 
prior to baseline testing. 
The baseline test was conducted by giving each mouse 5 minutes to explore both 
compartments as desired. No injection was administered prior to baseline testing. Time spent in 
each compartment was assessed and an unbiased design was employed. 
On days 2 through 9, mice received alternating injections of saline (vehicle) and cocaine 
hydrochloride (drug) as described above. Animals were injected and immediately sequestered to 
either the drug-paired or the vehicle-paired compartment for 15 minutes based on which 
injection they received. Injection schedule and the drug-paired compartment was 
counterbalanced across genotypes. All surfaces were thoroughly cleaned between animals. 
On the day of the preference test, no injections were administered. Mice were placed on 
the boundary connecting the two compartments and given 30 minutes to explore both 
compartments freely. Time spent in each compartment and total movement were scored using 
EthoVision XT version 11.5 behavior software (Noldus Information Technologies, Inc.). 
Preference was assessed by dividing the time spent in the drug-paired compartment by the total 
time in the chamber. 
Forced Swim Test 
A drug solution was prepared by combining 0.167 mg/mL fluoxetine hydrochloride 
(Sigma-Aldrich, PHR1394) and 10 g/L sodium saccharin (Sigma-Aldrich, S1002) in tap water. 
Control mice received only 10 g/L sodium saccharin in tap water. Water was provided ad libitum 
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in 50 mL drinking bottles and changed every three days over an 18 day period. Mice were group 
housed throughout administration and testing. 
On the day of testing, clear acrylic swim cylinders (30 cm x 30 cm) were filled to 18 cm 
with room temperature water. Mice were gently lowered into the water and recorded for 6 
minutes, before being removed and placed in a fresh, pre-warmed cage. Upon completion of the 
study, the last 4 minutes of each test were manually scored for immobility. To assess estrous 
cycle stages, cells were collected posthumously via vaginal lavage with physiological saline. 
Solution was stained using the Dip Quick Stain Kit (JorVet, J0322) as per manufacturer’s 
instructions. Cytology was assessed in accordance with previously published literature (Byers, 
Wiles, Dunn, & Taft, 2012; Cora, Kooistra, & Travlos, 2015). 
Tail Suspension Test  
Drug preparation and administration was carried out identically to the forced swim test. 
The apparatus was constructed from white acrylic and consisted of four, 3-walled chambers. 
Each chamber was 4.5 cm x 15 cm x 55 cm (l x w x h) with 1 cm notches cut out of the top. A  
1 cm x 1 cm aluminum suspension bar was fitted into the notches across the top of the apparatus. 
Because mice from a C56BL/6 background have a tendency to climb their tails as a means of 
escape, climbstoppers were made of PVC piping. Climbstoppers were fitted over the tail and tape 
was attached toward the end of the tail, then the tape was attached to the suspension bar. Mice 
were recorded for 6 minutes before being placed back in home cages. Upon completion of the 






Toe samples were collected from mice P7-P9. DNA was extracted using the Phire 
Animal Tissue Direct kit II (ThermoFisher Scientific, F140WH) according to the manufacturer’s 
instructions. PCR solutions were prepared using AmpliTaq Gold® 360 mastermix (Thermo 
Fisher Scientific, 4398881) and primers flanking the e18a site (F-MT: 
5’CCATGTCTGCTGCCAATATCT, F-WT: 5’GCAGCAGAGGTTCTGTTTGC, and R-C: 
5’CTCGGTGCTTTCTGTCCTGTCC) (Table 2). PCR conditions were as follows: initial 
denaturation at 95°C for 10 min, 35 cycles (95°C for 30 sec, 60°C for 30 sec, 72°C for 1 min), 
and final elongation at 72°C for 7 min. Expected bands were visualized at 880 bp for WT 
animals and at 395 bp for Δ18a-only mice. 
 
Table 2. Endpoint PCR primers for verification of Δ18a and WT mouse genotypes. 
Mouse line Primers Expected products 
Δ18a-only F-MT: CCATGTCTGCTGCCAATATCT 
F-WT: GCAGCAGAGGTTCTGTTTGC 
R-C: CTCGGTGCTTTCTGTCCTGTCC 
Hom: 395 bp  
Het: 395 and 880 bp 
WT: 880 bp 
 
 
BaseScope™ In-situ Hybridization 
 All tissues were obtained from WT C57BL/6 male mice aged P30 or older, as e18a 
splicing patterns are relatively consistent from age P30. Mice were deeply anesthetized with 
isofluorane and injected with either 0.07 mL (mice under 40 g body weight) or 0.1 mL (mice 
over 40 g body weight) of Euthasol (Virbac, 200-071). Once asleep, a transcardial perfusion was 
performed for 10 min using ice cold 1x phosphate buffered saline (PBS; Sigma, P3813) followed 
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by 10 min of ice cold 10% neutral buffered formalin (NBF; Sigma, HT501128) followed by 
another 10 min of ice cold 1x PBS. The brain was quickly extracted and fixed in 10% NBF at 
4°C for at least 24 hrs. Following fixation, the brain was rinsed with 1x PBS and cryoprotected 
in 15% sucrose in PBS followed by 30% sucrose in PBS until tissue was saturated. Brains were 
fixed in optimal cutting temperature compound (OCT; Fisher, 4585) and frozen in pre-chilled 
isopentane on dry ice. The OCT block was acclimated in a cryostat for at least 1 hr prior to 
cryosectioning. 12 μm sections were placed in Netwell™ inserts (Corning, 3478) on dry ice and 
transferred to 1x PBS for float mounting on positively charged microscope slides (Globe 
Scientific, 1358). 
 All BaseScope™ duplex reagents were included in a kit (Advanced Cell Diagnostics, 
323800). Prior to the assay, tissues were pretreated using an optimized tissue detachment 
protocol and RNAscope™ pretreat reagents. Slides were air-dried for at least 1 hr followed by 
drying at 60°C for 30 min. Dried slides were fixed in 10% NBF pre-chilled to 4°C for 15 min. 
Following fixation, slides were sequentially dehydrated in 50%, 70%, and two rounds of 100% 
ethanol for 5 min each and allowed to dry at room temperature (RT) for 5 min. Sections were 
incubated with RNAscope® Hydrogen Peroxide for 10 min and rinsed twice with fresh Milli-Q® 
water. Slides were transferred to 99°C Milli-Q® water for ~15 s then incubated for 5 min 
incubation in 99°C RNAscope® 1x Target Retrieval Reagent. Slides were then rinsed in RT 
Milli-Q® water for ~15 s, dehydrated in 100% ethanol for 3 min, and dried at 60°C for 5 min. An 
ImmEdge™ hydrophobic barrier pen (Vector Laboratories, H-4000) was used to draw a barrier 
around each section and dried at RT overnight. 
 The following day, RNAscope® Protease III was applied to each section and incubated at 
40°C for 30 min in the pre-warmed HybEZ™ Hybridization System (ACD, 310016) followed by 
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two washes in 1x RNAscope® Wash Buffer (ACD, 310091). The Channel 1 (C1) green probe for 
all experiments spanned 4 exon junctions within Slc6a3 mRNA for the dopamine transporter 
(DAT; ACD, 722171). Two Channel 2 (C2) red probes were designed: one spanned 4 exon 
junctions of Cacna1b mRNA (CaV2.2; ACD, 722451-C2) and the other spanned the e18:e18a 
exon junction of Cacna1b (e18a; ACD, 701141-C2). The C1 and one of the C2 probes were 
mixed together in a 50:1 ratio, dropped onto each section, and incubated as before. The rest of 
the BaseScope™ assay was performed as per manufacturer’s instructions, with the exception of 




Prior to behavioral screening, we performed a number of experiments to validate that our 
Δ18a-CaV2.2 mouse model contains successful deletion of e18a and does not demonstrate 
alterations in CaV2.2 mRNA or protein expression. Following validation, we performed an 
extensive behavioral screening to determine differences evoked by removal of e18a. Because 
CaV2.2 is involved in nociception, exploratory behavior, locomotion, we performed tasks to 
probe these behaviors. In addition, we tested behavioral response to appetitive stimuli, to 
examine the possibility of an anhedonic phenotype. 
 
Validation of the Mouse Genetic Model to Study e18a Splice Variants 
In order to study the function of e18a, we developed a mouse model in which e18a was 
globally deleted from the genome (18a-only). We also generated another mouse that contains 
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constitutive inclusion of e18a (+18a-only). However, we did not perform a thorough behavioral 
characterization of this mouse because the forced inclusion of e18a resulted in the expression of 
+18a-Cacna1b in cells where it is not normally expressed, therefore complicating the 
interpretation of our results (Fig. 5). This mouse will be used for other type of experiments and 
therefore was also validated. 
 
Figure 5. Mouse models developed to study impacts of restricted splice choice. WT Cacna1b contains intronic 
regions which flank e18a and enable its selective inclusion in or exclusion from mature Cacna1b mRNAs (and as a 
result, CaV2.2 channels). Using homologous recombination, we developed mouse models in which the intronic 
regions flanking e18a were missing. In the +18a-only mouse, e18a is fused to e18a and e19, enabling production of 
only +18a-Cacna1b transcripts. In the Δ18a-only model, exons 18 and 19 are fused together and e18a is removed 
from the genome completely, resulting in only Δ18a-Cacna1b transcripts. RT-PCR of WT, +18a-only, and Δ18a-
only whole brains demonstrates that this genetic manipulation was successful—no Δ18a-Cacna1b mRNA was 




To rule out non-specific effects of our genomic manipulation we performed a thorough 
validation of our mouse models. We quantified the total protein levels for CaV2.2 and we also 
assessed if other splicing events within the Cacna1b pre-mRNA were altered. To quantify 
protein expression, we performed Western blots on whole brain using CaV2.2-specific 
antibodies. At approximately 230-260 kDa, WT samples exhibit a thick band which CaV2.2-null 
control brains lack (Fig. 6A, left panel). Whole protein was consistent across lanes in the loading 
control (Fig. 6A, right panel), indicating that this 230-260 kDa band is CaV2.2. Next, CaV2.2 
expression levels were compared in WT and Δ18a-only males and females (Fig. 6B, left panel). 
All samples exhibited a thick CaV2.2 band in the 230-260 kDa range. Following whole protein 
quantification and normalization against the loading control, we found no differences in CaV2.2 




Figure 6. Validation that restriction of e18a splice choice does not impact CaV2.2 protein expression using Western 
blot. (A) Western blot of proteins purified from +18a-only, CaV2.2-null, and Δ18a-only brains (left) and whole 
protein loading control (right). CaV2.2 appears at ~230-260 kDa in +18a-only and Δ18a-only samples but is absent 
from CaV2.2-null samples. Therefore, the antibody is CaV2.2-specific and detects both +18a-CaV2.2 and Δ18a-
CaV2.2 proteins. Normalization against the loading control shows that protein expression is consistent. (B) Western 
blot of male and female WT, +18a-only, and Δ18a-only whole brain samples (left) and whole protein loading 
control (right). CaV2.2 antibody shows expected bands in all samples at the 230-260 kDa mark, and normalization 
against the loading control showed that protein expression is consistent across all genotypes and both sexes.  
(C) Graphical depiction of relative CaV2.2 expression in female and male WT, +18a-only, and Δ18a-only samples. 
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To ensure that restricting e18a splice choice does not impact other alternative splicing 
events, we quantified mRNA expression of another alternatively spliced exon within CaV2.2, 
exon 37a. qPCR primers were designed to detect both the constitutively expressed exon 35-36 
junction and the alternatively spliced exon 36-37a junction (Fig. 7A, 7B, and 7C). Probe 
specificity was confirmed using an endpoint PCR reaction of cDNA that was RT-PCR amplified 
from whole brain samples of WT and Δ18a-only mice. Both WT and Δ18a-only samples 
produced bands of the expected size, ~90 bp for the 36-37a probe and ~90 bp for the 35-36 probe 
(Fig. 7D). qPCR of these samples and normalization against exon 35-36 expression 
demonstrated similar exon 37a expression levels in both WT and Δ18a-only brains (Fig. 7E). 






Figure 7. Validation that restriction of e18a splicing does not impact expression of other alternatively spliced exons. 
(A) Exons 37a and 37b of Cacna1b pre-mRNA undergo mutually exclusive alternative splicing, and exons 35, 36, 
45, and 46 of Cacna1b are constitutively expressed. We employed a TaqMan® assay using a probe which overlaps 
exons 45 and 46 to track new strand synthesis. Primer pairs spanning the 35:36 junction and the 36:37a junction 
were used. (B) Melt curve analysis of 35-36 and 36-37a primer sets demonstrates that each set has only one peak 
and that they dissociate at approximately the same temperature. (C) qPCR primer efficiency for each primer set is 
within acceptable limits, indicating high quality primers. (D) Endpoint PCR bands showing products amplified by 
36-37a and 35-36 primers. Equally sized products were obtained in bacterial cDNA of transfected 37a and 37b 
clones (top) and in WT, +18a-only, and Δ18a-only mouse whole brain cDNA samples (bottom). The top panel 
demonstrates that primer set 36-37a cannot amplify product without the presence of e37a. Therefore, primers are 
acceptable for use in all three genotypes and they will recognize the 35-36 and 36-37a sequences with high 
specificity. (E) Mean (filled circles) and individual (empty circles) e37a fold change. E37a expression was 
normalized to 35:36 expression and fold change was analyzed using the 2-ΔΔCt method. Expression of e37a is 
consistent in WT, +18a-only, and Δ18a-only samples, demonstrating that altered e18a splicing does not impact other 
alternatively spliced Cacna1b exons. WT: n = 4, +18a-only: n = 4, Δ18a: n = 4. (F) Cacna1b total gene expression 
level comparison. Cacna1b-35:36 qPCR primer products were normalized to Gapdh levels and fold change was 
assessed as before. No differences were found in Cacna1b whole gene expression in WT, +18a-only, and Δ18a-only 
animals, indicating that altered e18a splicing does not impact Cacna1b whole gene expression. WT: n = 8, +18a-





Exon 18a Does not Influence Nociceptive Behavior 
Previous results have shown that CaV2.2 channels control transmitter release of sensory 
afferents into the spinal cord, and thereby are involved in nociceptive behavior (Heinke, Balzer, 
& Sandkühler, 2004). CaV2.2-KO mice exhibit delayed responses to thermal stimuli in hot plate 
and Hargreaves tests (Hatakeyama et al., 2001; Kim et al., 2001). Therefore, we compared global 
nociceptive responses to a thermal stimulus between WT and 18a-only mice. We assessed the 
time to paw withdrawal, paw licking or jumping at three different temperatures (50, 53 and 
55oC).  As expected, a two-way repeated measures ANOVA revealed a significant effect of 
temperature (F = 161, p < 0.001), which simply demonstrates a general increase to 
responsiveness with heightened temperatures. There was no significant effect of genotype (F = 
1.44, p = 0.27), or genotype x temperature (F = 0.92, p = 0.39), suggesting that the absence of 





Figure 8. Thermal nociceptive responses time at 50, 53, and 55°C in the hot plate test. The same animals were used 
in all three trials. Black circles represent WT animals and grey circles represent Δ18a-only. Filled circles are 
averages while empty circles represent individuals. For both WT and Δ18a-only, average time to respond 
significantly decreased with increasing temperature, as expected (F = 161, p < 0.001). WT and Δ18a-only mice did 






E18a Does not Impact Baseline Response to an Appetitive Stimulus 
 Preference for a sweet reward has been associated with a hedonic state, particularly 
monoaminergic function has been implicated in saccharin preference (Matthews, Gibson, & 
Booth, 1985; Sclafani, Touzani, & Bodnar, 2011). As part of our baseline screening, we used the 
saccharin preference test to probe for altered sweet reward response indicative of a potential 
anhedonic state or monoaminergic modulation. Mice were given two bottles of DI water for 4 
days, followed by 4 days with one bottle of DI water and one bottle of saccharin water. As 
expected, mice showed no consistent baseline preference for one water bottle over the other, with 
average preference ranging from 35-60%. On day 1 of testing, all mice developed a preference 
for the saccharin water, and after day 1 of testing, all mice showed ≥90% preference for the 
bottle of saccharin water. Two-way repeated measures ANOVA revealed a significant effect of 
testing phase as expected (F = 211.7, p < 0.001) but revealed no significant effect of genotype  
(F = 0.457, p = 0.509) or genotype x testing phase (F = 0.463, p = 0.507) (Fig. 9). Therefore, we 




Figure 9. Bottle preference during baseline (days -3 through 0) and 0.2% saccharin preference testing (days 1 
through 4). Data shown as average ± SEM. Black circles are WT, grey circles are Δ18a-only. During baseline days 
mice were given two bottles with water only, and showed roughly equal preference for both bottles. At testing day 1, 
one bottle per cage was switched with 0.2% saccharin water. All mice exhibited >75% preference for the saccharin 
bottle during all 4 testing days and this preference was consistent in WT and Δ18a-only mice (F = 0.457, p = 0.509). 






Removal of Exon 18a Does not Impact Responses to Appetitive Stimuli under mild stress  
We next assess if lack of e18a impacts the appetitive responses of mice but under a 
mildly stressful environment. To do this, we performed the novelty-induced hypophagia test in 
WT and 18a-only mice. In this task, mice must overcome a mildly stressful relatively novel 
stimulus to receive an appetitive reward. Mice were trained for three days to locate a sipper tube 
of sweetened milk in their home cage under dim lighting. On the fourth day home cage latency 
and time spent drinking were timed. On the final day, mice were placed in a bright, empty cage 
and latency as well as time drinking were again measured. As expected, all individuals spent less 
time drinking in the novel cage (Fig. 10A, left panel), and all but one individual exhibited higher 
latencies to find the bottle in novel conditions (Fig. 10B, left panel). Average time spent drinking 
in the home cage did not differ between WT and Δ18a-only mice, although Δ18a-only mice 
displayed a small, nonsignificant trend towards higher home cage latencies (Time spent drinking, 
mean ± SEM: WT home = 133.3 ± 9.6 s; Δ18a-only home = 128.4 ± 8.9 s. Student’s t-test,  
p = 0.71. Fig. 10A, left panel. Latency to drink, mean ± SEM: WT home = 9.5 ± 1.5 s; Δ18a-
only home = 14.6 ± 2.2 s. Student’s t-test, p = 0.07. Fig. 10B, left panel). Drinking time and 
latency to approach in the novel cage did not differ based on genotype (Time spent drinking, 
mean ± SEM: WT novel = 57.3 ± 6.6 s; Δ18a-only novel = 55.3 ± 8.8 s. Student’s t-test,  
p = 0.85. Fig. 10A, left panel. Latency to drink, mean ± SEM: WT novel = 49.4 ± 10.9 s; Δ18a-
only novel = 60.9 ± 11.3 s. Student’s t-test, p = 0.47. Fig. 10B, left panel.) Similarly, change in 
time spent drinking and change in latency did not differ by genotype (Δ time drinking, mean  
± SEM: WT = 75.9 ± 8.8 s; Δ18a-only = 73.1 ± 6.8 s. Student’s t-test, p = 0.8. Fig. 10A, right 
panel. Δ latency to approach, mean ± SEM: WT = 39.9 ± 10.5 s; Δ18a-only = 46.3 ± 10.4 s. 
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Student’s t-test, p = 0.67. Fig. 10B, right panel). We conclude that e18a does not modify 
behavioral response to appetitive stimuli under conditions of mild stress. 
 
Figure 10. Comparison of novelty-induced hypophagia in WT and Δ18a-only mice. Black circles represent WT 
animals and grey circles are Δ18a-only. Empty circles represent individuals and filled-in circles represent average 
with SEM. Days 1-3 were habituation to the new environment in the home cage where normal water bottles were 
replaced with sweetened milk. Day 4 was home cage (HC) testing under the same conditions, tracked for 10 min. 
Day 5 mice were placed in an empty, brightly-lit, novel cage (NC) and tracked for 10 min again. (A) Total time 
spent drinking for WT and Δ18a-only individuals (left) and change in time spent drinking (right). The novel cage 
consistently induced a decrease in time drinking; however, genotype did not affect drinking in either assessment 
(Time spent drinking: p = 0.85; Δ Time spent drinking: p = 0.8). (B) Latency to approach the bottle (left) and change 
in time to approach the bottle from HC to NC (right). WT and Δ18a-only mice take longer to approach the sweet 
milk in most cases upon exposure to the novel environment. No difference was seen in average time to approach or 
change in approach time between genotypes (Time to approach (s): p = 0.47; Δ Time to approach: p = 0.67). WT: n 




Lack of e18a-Cacna1b does not influence exploratory behavior 
Previous studies have shown that the CaV2.2-KO mice displayed enhanced exploratory 
behavior in the open filed (OF) and elevated plus maze (EPM) (Saegusa et al., 2001). 
Furthermore, recent evidence suggests Cacna1b alternative splicing in the e37a/e37b locus is 
linked to exploratory behavior (Bunda, LaCarubba, Bertolino, et al., 2019). We tested if splicing 
of e18a impacts exploratory behavior in OF and EPM. In OF, we tracked number of entries into 
the center, time spent in the center versus the outer perimeter of an open chamber, and total 
distance traveled. No differences were found in any parameter based on genotype (# of entries 
into center, mean ± SEM: WT = 14.4 ± 1.6; Δ18a-only = 17.4 ± 1.7. Student’s t-test, p = 0.22. 
Fig. 11A, left panel. % time in center, mean ± SEM: WT = 11.8 ± 2.3; Δ18a-only = 13.1 ± 1.5. 
Student’s t-test, p = 0.65. Fig. 11A, middle panel. Distance traveled, mean ± SEM: WT = 1648  
± 85.7 cm; Δ18a-only = 1670.3 ± 86.3 cm. Student’s t-test, p = 0.86. Fig. 11A, right panel). 
Similar results were observed in the EPM apparatus. No differences in percent of entries into the 
open arms (OA), time in OA and total locomotion, were observed between WT and Δ18a-only 
mice (% entries into OA, mean ± SEM: WT = 35.1 ± 1.9. Student’s t-test, p = 0.99. Fig. 11B, left 
panel. % time in OA, mean ± SEM: WT = 18 ± 3.4; Δ18a-only = 14.7 ± 1.6. Student’s t-test,  
p = 0.4. Fig. 11B, middle panel. Distance traveled, mean ± SEM: WT = 1910 ± 81.9 cm;  
Δ18a-only = 1927.7 ± 72.5 cm. Student’s t-test, p = 0.87. Fig. 11B, right panel.) These results 




Figure 11. Comparison of exploratory behavior and total locomotion between WT and 18a-only mice. Data is 
shown as mean (filled circles) ± SEM and individual data points (empty circles). Black circles represent WT animals 
and grey circles represent Δ18a-only animals. Data for males and females is provided, all animals were used in both 
paradigms. (A) Entries into center, time in center, and total distance traveled in the 5 minute OF paradigm did not 
differ between the genotypes (Entries into center: p = 0.22; Time spent in center (%): p = 0.65; Distance traveled 
(m): p = 0.86). (B) Entries into open arms, time spent in open arms, and total distance traveled in the 10 minute 
elevated plus maze test also did not differ based on genotype (Entries into open arms (%): p = 0.99; Time spent in 
open arms (%): p = 0.4; Distance traveled (m): p = 0.87). In all analyses, WT and Δ18a-only mice did not differ in 
behavioral response or basal locomotion. WT: n = 16, Δ18a-only: n = 14.  
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Δ18a-only Mice Exhibit Increased Immobility during Habituation to New Environments 
We next performed a detailed analysis of locomotor behavior in both males and females. 
This analysis made it possible to elucidate whether mice show genotypic differences in the 
habituation to a novel environment. During the first 5 minutes of the OF test, we found that 
compared to WT mice, 18a-only male mice exhibited a significant reduction in overall distance 
traveled (Distance traveled, mean ± SEM: WT = 1927.5 ± 91.2 cm; Δ18a-only = 1572.8 ± 72 
cm. Student’s t-test, p = 0.01. Fig. 12A, left panel). After the first 5 minutes, WT and Δ18a-only 
mice were similar in locomotor activity (Fig. 12A, left panel). During the first 2 minutes of EPM 
we noticed a trend towards Δ18a-only mice moving less, and during the 2-4 minute time period 
they moved significantly less (Distance traveled 0 to 2 minutes, mean ± SEM: WT = 526.6  
± 34.3 cm; Δ18a-only = 458.6 ± 16.9 cm. Student’s t-test, p = 0.16. Fig. 12B, left panel. Distance 
traveled 2 to 4 minutes, mean ± SEM: WT = 460.9 ± 22.8 cm; Δ18a-only = 384.7 ± 17.8 cm. 
Student’s t-test, p = 0.03. Fig. 12B, left panel). By contrast, female locomotion during 
acclimation was similar at all times analyzed (Distance traveled OF, mean ± SEM: WT = 2030.1 
± 84.4 cm; Δ18a-only = 2104 ± 48.8 cm. Student’s t-test, p = 0.59. Fig. 12A, right panel. 
Distance traveled EPM 0-2 minutes, mean ± SEM: WT = 592.6 ± 27 cm; Δ18a-only = 583.3  
± 39.1 cm. Student’s t-test, p = 0.85. Fig. 12B, right panel. Distance traveled EPM 2-4 minutes, 
mean ± SEM: WT = 490.6 ± 26.7 cm; Δ18a-only = 530.5 ± 20.6 cm. Student’s t-test, p = 0.41. 
Fig. 12B, right panel). No differences were found in the time spent in the center or number of 
transitions to the center in either males or females (data not shown). We observed similar results 
for both males and females in the EPM test, percentage of entries into the OA and percentage of 
time in the OA was similar for both genotypes at all times (data not shown). These results 
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suggest that Δ18a-only mice are more immobile than WT mice when acclimating to new 
environments in which no appetitive stimuli are present.  
To determine with measure with more accuracy mouse movement in a novel 
environment, we performed pixel subtraction in a fear conditioning chamber (a context that mice 
have never been exposed). Pixel subtraction allows for measurement of freezing. In this task, 
males and females were combined. Δ18a-only mice spent nearly twice as much time freezing as 
their WT counterparts during a period of 3 minutes (% of time freezing during acclimation, mean 
± SEM: WT = 15.9 ± 2.8; Δ18a-only = 34 ± 4.6. Student’s t-test, p = 0.001. Fig. 12C). The 
increased freezing during acclimation to the chamber is consistent with the decreased locomotion 
in the first 5 minutes OF and EPM. Taken together, these data suggest that e18a-Cacna1b splice 





Figure 12. Differences in habituation to new environments in the open field (top panels), elevated plus maze 
(middle panels), and fear conditioning chamber (bottom panel) with males and females. Black circles represent 
averages for WT and grey circles are Δ18a-only averages. The same animals were used in OF and EPM (A) 
Distance traveled across 1 hour in an open field chamber, broken into 5-minute segments. Male Δ18a-only mice 
exhibit significantly less locomotor activity during acclimation (first 5 minutes) than their WT male counterparts 
(Distance traveled in first 5 minutes (m): p = 0.01). Females did not exhibit locomotor differences during any time 
period (Distance traveled (m): p = 0.59). WT males: n = 17; Δ18a-only males: n = 10; WT females: n = 21; Δ18a-
only females: n = 8. (B) Distance traveled during 10 minutes in an elevated plus maze, broken into 2-minute 
segments. Again, Δ18a-only male locomotion is slightly attenuated (first 0-2 minutes) and significantly attenuated 
(2-4 minutes) during acclimation (Distance traveled in minutes 0-2 (m): p = 0.16; Distance traveled in minutes 2-4 
(m): p = 0.03). Locomotion analysis in female mice shows consistent results, with no genotypic differences 
(Distance traveled in minutes 0-2 (m): p = 0.85; Distance traveled in minutes 2-4 (m): p = 0.41). WT: n = 17; Δ18a-
only: n = 10; WT females: n = 21; Δ18a-only females: n = 8. (C) Percent of time spent freezing (immobile) during 
the 2.5-minute acclimation period to a fear conditioning chamber. Males and females were combined for this 
analysis. On average, Δ18a-only mice spend significantly more time freezing during acclimation than their WT 
counterparts (% Freezing: p = 0.001). WT: n = 35; Δ18a-only: n = 16. 
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Removal of e18a Results in Heightened Stress-Induced Inactivity 
Based on our OF, EPM, and FC data we noted that Δ18a-only mice exhibited higher rates 
of immobility in response to new environments compared to WT mice. However, we did not 
observe differences between the two genotypes in response to novelty when there is appetitive 
stimulus present (Fig. 10). We next assessed the response of the mice to several stressful stimuli 
without reward. To test this, we used three different measures of stress: the marble burying test 
(MBT), the tail suspension test (TST) and the forced swim test (FST).  
Marble burying is a test of anxious or repetitive behaviors and has been shown to be 
sensitive to a number of antipsychotics that act as monoaminergic ligands (Bruins Slot, Bardin, 
Auclair, Depoortere, & Newman-Tancredi, 2008). Male mice were placed on bedding that was 
dirtied by irrelevant male mice and given 1 hour to bury twenty marbles. After an hour, Δ18a-
only mice showed a strong trend towards burying fewer marbles than their WT counterparts (# of 
marbles buried, mean ± SEM: WT = 11.7 ±1.8; Δ18a-only = 7.2 ± 1.3. Student’s t-test,  
p = 0.053. Fig. 13A). 
The FST was used to measure escape-oriented behavior in response to inescapable swim 
stress. Mice were placed in room temperature water tanks and the last 4 minutes of the 6 minutes 
were scored for immobility. When male mice were tested, we saw significantly less average 
mobility in Δ18a-only mice compared with WT mice (Immobility, mean ± SEM: WT = 51.7  
± 18.4 s; Δ18a-only = 131.2 ± 14.3 s. Student’s t-test, p = 0.009. Fig. 13B, left panel). However, 
this phenotype was not observed in females (Immobility, mean ± SEM: WT = 176.3 ± 27.8 s; 
Δ18a-only = 157.6 ± 21.6 s. Student’s t-test, p = 0.6. Fig. 13C), and nicely correlates with our 
previous observations in OF and EPM. 
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In the TST, male mice were taped to a suspension rod and escape-oriented behavior was 
scored as immobility. Again, only the last 4 minutes of the 6 minute test were scored. As 
expected, Δ18a-only mice were more immobile on average than WT mice (Immobility, mean  
± SEM: WT = 148.4 ± 14.6 s; Δ18a-only = 192 ± 7.7 s. Student’s t-test, p = 0.02. Fig. 13B, right 
panel). Thus, both of these paradigms are in agreement and provide evidence that removal of 
e18a results in heightened immobility in response to inescapable stress. 
 
 
Figure 13. Black, filled circles represent averages ± SEM for WT and grey, filled circles are Δ18a-only averages  
± SEM. Individual subjects are depicted as empty circles. (A) Percent of marbles buried when males were placed on 
bedding dirtied with competing male odor. WT animals show near-significant increases in total percent buried 
compared to Δ18a-only mice (% Buried marbles: p = 0.053). WT: n = 11; Δ18a: n = 11. (B) Immobility in seconds 
during the FST (left panel) and TST (right panel). In both of these tests, Δ18a-only males were significantly more 
immobile compared to their WT counterparts (Immobility in FST (s): p = 0.009; Immobility in TST (s): p = 0.02). 
WT FST: n = 6; Δ18a-only FST: n = 5; WT TST: n = 16; Δ18a-only TST: n = 13. (C) Immobility of female WT and 
Δ18a-only mice in the FST under the same conditions as males. No genotypic differences were detected, in line with 





Cocaine-Induced Conditioned Place Preference Is Mildly Affected by e18a Removal 
To narrow down the potential role of e18a in monoamine-linked behavior, we chose to 
test conditioned preference for a drug that has a high affinity for one specific transporter. 
Cocaine is a stimulant that potently blocks dopamine influx through DAT in vivo (Verma, 2015). 
In an unbiased design, we trained mice over a period of eight days to associate a conditioning 
chamber with an i.p. injection of cocaine hydrochloride and an unconditioned chamber with i.p. 
injection of saline. Time spent in the drug-paired chamber versus the unpaired (saline) chamber 
was measured after the final day of conditioning and without injection. While both genotypes 
spent significantly more time in the drug-paired chamber than the unpaired chamber (data not 
shown), Δ18a-only mice spent slightly more time in the paired chamber compared to WT mice 
(Time in paired chamber, mean ± SEM: WT = 1469.8 ± 58.4 s; Δ18a-only = 1607 ± 41.7 s. 
Student’s t-test, p = 0.09. Fig. 14A). Time spent in the paired chamber was divided by time spent 
in the unpaired chamber to determine the ratio of preference. Δ18a-only mice again showed a 
trend towards greater ratio of preference, although this trend was nonsignificant (Ratio of 
preference, mean ± SEM: WT = 6.8 ± 1.7; Δ18a-only = 13.4 ± 4. Student’s t-test, p = 0.12. Fig. 
14B). A power analysis showed that we would need 35 animals from each genotype in order to 





Figure 14. Preference for drug-paired chamber in cocaine-conditioned place preference post-test. Filled circles are 
mean ± SEM and empty circles represent individuals. Mice were given a pre-test to check for bias, then given a 
series of i.p. injections with either saline or cocaine and sequestered to one compartment, which was 
counterbalanced across genotypes and day of training. Injections were alternated each day for 8 days, and the drug-
paired compartment was kept consistent each day. After a 24-hour rest, mice were post-tested with no injection for 
conditioned place preference, measured by the time willingly spent in the drug-paired compartment over the 
unpaired compartment. (A) Total time spent in the drug-paired chamber, in seconds. Both genotypes spend more 
time in the drug-paired chamber compared to the unpaired chamber; however, there is a nonsignificant trend for 
Δ18a-only mice to spend more time in the paired chamber than the WT mice (Time in paired chamber (s): p = 0.09). 
(B) Ratio of preference for drug-paired chamber, calculated by dividing time spent in drug-paired compartment by 
total time in the chamber. In this analysis, Δ18a-only mice again show a slight, nonsignificant increase in preference 







   
    
    
    









































Colocalization Studies of Cacna1b and e18a with Slc6a3 (Dopamine transporter)  
 We and others have previously shown shown extensive expression of +18a-Cacna1b in 
the VTA and SNc, two major dopamine production centers in the midbrain. Howeve, whether 
this splice variant is enriched in dopamine neurons is unknown. We attempted to perform 
colocalizaion studies using BaseScope™ Duplex Assay. In these experiments, we performed a 
dual assay experiment to determine +18a-Cacna1b colocalization with Slc6a3. Independently, 
we performed a dual assay experiment to determine total Cacna1b mRNA with Slc6a3. mRNA 
for +18a-Cacna1b and Cacna1b mRNA can be quantified by counting the red dots, since each 
dot is equivalent to one mRNA molecule.  In line with previous findings, Cacna1b is expressed 
extensively in the dopaminergic midbrain (Fig. 15A). In both the VTA and the SNc, Cacna1b 
colocalizes with a subpopulation of Slc6a3-positive cells; however, Cacna1b is also expressed in 
Slc6a3-negative cells, and some cells expressing DAT do not express Cacna1b (Fig. 15B and 
15C). Regarding +18a-Cacna1b, despite multiple efforts and rounds of optimization, our probe 
did not work for this experiment (Fig. 16A, 16B, and 16C). Therefore, we were unable to 




        
Figure 15. Expression of Slc6a3 (dopamine transporter) and Cacna1b (CaV2.2) mRNA in the VTA and the SNc. 
BaseScope™ Duplex Assay was conducted on WT mice only (but see Bunda et al., 2019 for Δ18a-only controls). 
Each punctate dot of red or green represents one mRNA molecule for Cacna1b or Slc6a3, respectively. Top panel 
(A) was taken at 10x magnification and bottom panels (B and C) were taken at 20x. We observed partial 








             
Figure 16. Localization of Slc6a3 (dopamine transporter) and e18a of Cacna1b (CaV2.2) in the VTA and SNc. Each 
punctate dot of red or green represents one mRNA molecule for +18a-Cacna1b or Slc6a3, respectively. Top panel 
(A) was taken at 10x magnification and bottom panels (B and C) were taken at 20x. E18a can be sparsely observed 
within the VTA and the SNc areas and seems to colocalize with DAT in some cases; however, due to extremely 








Alternative splicing is a fascinating and nearly ubiquitous aspect of eukaryotic cellular 
biology. It is thought to fine-tune protein function based on tissue-, development-, and cell-
specific needs. The importance of alternative splicing to CaV2.2 function has already been 
demonstrated with e37a/e37b, where the exons modulate nociception and behavioral responses to 
aversive stimuli. Exon 18a of CaV2.2 has been shown to alter channel’s calcium dynamics in 
vitro and exhibits a striking pattern of heightened expression within monoaminergic areas of the 
midbrain and sympathetic system. Based on this evidence, e18a is suspected to assist in fine-
tuning the neural bases for mood. 
In our baseline behavior screening, appetitive stimuli failed to produce a phenotypic 
difference between WT and Δ18a-CaV2.2 (Δ18a-only) mice. In the saccharin preference test, 
orally administered saccharin water was highly preferred (≥90%) by both genotypes after day 1 
of testing. It is possible that the saccharin concentration reached a point of saturation at which 
differences between genotypes would be indistinguishable. However, when comparing the 
drinking times in their come cages in the novelty-induced hypophagia test, we observed similar 
results to the ones obtained in the saccharin test. These results strongly suggest that the absence 
of +18a-Cacna1b splice variant does not impact hedonia. 
We did not detect differences in exploratory behavior in the OF and EPM. However, 
during the first five minutes of acclimation, Δ18a-only mice were more immobile in both tasks, 
indicating an altered phenotype in response to novel environment. This phenotype was observed 
only in males but in females. Differences in estrous cycle might explain this, and larger number 
of individuals would be needed to determine with more certainty if e18a is important for 
behavioral responses of females to a novel environment. 
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We next assessed the behavioral responses of mice to stressful stimuli that includes 
novelty in the absence of reward—MBT, FST, and TST. In MBT, an irrelevant male’s odor was 
used to detect differences in odor-based stress response. Δ18a-only mice, on average, buried 
fewer marbles under this condition than WT mice. This test is traditionally a model of anxiety- 
and obsessive/compulsive-like behavior (Deacon, 2006). Based on our OF and EPM data, we do 
not believe the differences in MBT are due to an anxiety-like state, we think are findings can be 
explained by differences in immobility induced by stress based on the odor of another male. 
To test behavior strictly linked to stress-induced immobility, FST and TST were 
administered. In both cases the Δ18a-only mice showed heightened immobility compared to WT 
mice. While these tests are not considered to be reliable measures of depression or learned 
immobility (Commons, Cholanians, Babb, & Ehlinger, 2017; De Kloet & Molendijk, 2016; 
Molendijk & de Kloet, 2015), they have high predictive validity when testing selective serotonin 
reuptake inhibitors, indicating that the tests are sensitive to serotonergic modulation (Petit-
Demouliere, Chenu, & Bourin, 2005). Therefore, the heightened immobility could be attributed 
to depletion of serotonin or decreased serotonin release from midbrain serotonergic neurons. 
This is in line with our previous findings showing robust expression of +18a-Cacna1b in the 
DRN. 
Cocaine potently inhibits dopamine reuptake through the dopamine transporter (DAT) 
(Verma, 2015) and the predicted rewarding effects of cocaine have been associated with 
dopaminergic activity (Koob & Volkow, 2010; Wu et al., 2014); therefore, we used cocaine to 
study differences in dopaminergic function in vivo. In an unbiased design, we taught WT and 
Δ18a-only mice to associate cocaine with one side of a conditioned place preference chamber 
through a series of i.p. injections. While we noted a trend toward higher preference in Δ18a-only 
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mice, this finding was not significant and we saw no differences in change of preference, 
regardless of whether the mouse was paired with the originally preferred chamber. Based on 
these results, it is possible that e18a has a subtle effect on dopaminergic communication; 
however, a power analysis demonstrates that we would need a much higher sample size (n = 35 
per genotype) to see significant results. We should also use a biased design in the future to 
mitigate ceiling effects and the possibility of conditioned place aversion. While cocaine is 
involved in reward, its potency and selectivity for the norepinephrine transporter and the 
serotonin transporter is similar to that of the dopamine transporter, and unlike humans, in mice 
its selectivity is slightly higher for the norepinephrine transporter (Han & Gu, 2006). Therefore, 
future tests would need to incorporate a mechanism that is more selective to the dopaminergic 
system, such as optogenetic inactivation paired with a biased conditioned place preference 
design (Zhang et al., 2015) or use of a selective DAT inhibitor like Difluoropine (Meltzer, Liang, 
& Madras, 1994). 
Finally, we used the BaseScope™ Duplex Assay in an attempt to detect colocalization of 
Slc6a3 (DAT, a dopaminergic marker) with Cacna1b and Cacna1b-e18a (CaV2.2 and +18a-
CaV2.2). Our data indicates that Cacna1b and Slc6a3 colocalize within a subpopulation of VTA 
and SNc cells. E18a seems to exhibit a similar pattern of expression; however, technical issues in 
either probe design or mRNA hybridization have made it impossible to accurately assess this 
portion of our data. In the upcoming months we hope to overcome this technical challenge and 
continue using the duplex assay to confirm colocalization of e18a with various cellular markers 
for other cell types which are expressed in the VTA and SNc. If this is not possible, we would 
propose using a retrograde tracer such as Fluoro-Gold™ to tag dopaminergic cells based on their 
projections, and use single-cell RT-PCR with e18a and Δ18a primers to identify relative 
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expression of channel isoforms in specific cell types. This would provide a clearer picture of 
+18a-CaV2.2 expression patterns, with major implications for the channel’s modulatory function. 
It has been demonstrated that CaV2.2 plays a pivotal role in dopamine release from 
midbrain dopaminergic areas (Brimblecombe et al., 2015). The cells of the VTA and SNc are 
heterogeneous, releasing dopamine, GABA, and glutamate, sometimes from the same cells 
(Cohen, Haesler, Vong, Lowell, & Uchida, 2012; Yoo et al., 2016). It has been demonstrated that 
GABAergic neurons in the VTA play important roles in sleep/wake cycles, and CaV2.2-KO mice 
demonstrate disturbances in these cycles (Beuckmann et al., 2003; Chowdhury et al., 2019). 
There is also some evidence to show that somatodendritic dopamine release is CaV2.2-dependent 
(Ford, Phillips, & Williams, 2010). Therefore, it is possible that CaV2.2 both directly and 
indirectly modulates dopamine release via release of other transmitters or autoregulation of 
dopaminergic neurons. While it has been established that dopamine release is calcium-
dependent, there is evidence to suggest that other calcium channels like CaV2.1 might aid the 
dominant CaV2.2 in controlling dopamine release (Dunlap et al., 1995; Phillips & Stamford, 
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